SEOM-TTCC clinical guideline in nasopharynx cancer (2021)

Clin Transl Oncol. 2022 Apr;24(4):670-680. doi: 10.1007/s12094-022-02814-x. Epub 2022 Mar 18.

Abstract

Nasopharyngeal carcinoma (NPC) is distinct from other cancers of the head and neck in biology, epidemiology, histology, natural history, and response to treatment. Radiotherapy (RT) is the cornerstone of locoregional treatment of non-disseminated disease and the association of chemotherapy improves the rates of survival. In the case of metastatic disease stages, treatment requires platinum/gemcitabine-based chemotherapy and patients may achieve a long survival time.

Keywords: Clinical Practice Guidelines; Diagnosis; Follow-up; Nasopharyngeal cancer; Treatment.

MeSH terms

  • Humans
  • Nasopharyngeal Carcinoma / therapy
  • Nasopharyngeal Neoplasms* / pathology